Quidel InflammaDry Sample Collectors Recall: Plastic Spurs Risk
Quidel recalls InflammaDry Sample Collectors with plastic spurs that could cause injury during use. Affected lots 1705405 and 170:1705359. Stop using immediately.
Stop using this now
In-house testing revealed the presence of plastic spurs at the tips of some Sample Collectors.
Contact the company
What happened, in plain English
Quidel recalls InflammaDry Sample Collectors due to plastic spurs at the tips that could cause injury. This affects specific lot numbers and requires immediate action to avoid potential harm. Read more at govinfonow.com/recall/73644-quidel-inflammadry-sample-collectors-recall-plastic-spurs-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/73644-quidel-inflammadry-sample-collectors-recall-plastic-spurs-risk · Updated September 22, 2026 · FDA enforcement record: FDA #Z-2803-2017
Cite this page
“Quidel InflammaDry Sample Collectors Recall: Plastic Spurs Risk.” GovInfoNow, updated September 22, 2026. https://govinfonow.com/recall/73644-quidel-inflammadry-sample-collectors-recall-plastic-spurs-risk. Based on FDA recall #Z-2803-2017 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2803-2017%22&limit=1).
Why it’s dangerous
Plastic spurs at the sample collector tips could cause injury during use. This hazard exists in some units and may lead to cuts or other injuries.
Who’s affected
Patients using InflammaDry Sample Collectors for dry eye diagnosis are affected. Those with the listed lot numbers are most at risk.
How to tell if you have this one
Check the lot numbers: 1705405 or 1705359. The product is a rapid dry eye test kit used for in-home diagnosis.
- Brand
Quidel- Category
Medical device
What to do — step by step
Stop Using Immediately
Discard the affected Sample Collectors with plastic spurs to prevent injury.
Where it went and when
Where it was distributed
Distributed nationwide; the notice names 30 states.
FDA distribution: “Nationwide Distribution including AR, AZ, CA, CO, CT, FL, GA, IL, IN, KY, LA, MA, MD, MI, MN, MO, NC, NE, NH, NJ, NY, OH, OK, PA, SC, SD, TX, VA, WA, & WV.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, South Dakota, Texas, Virginia, Washington, West Virginia.
Recall timeline
FDA terminated this recall 23 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-2803-2017 (June 22, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2803-2017 to see it in context.
- Plain-language summary written by qwen3:4b on September 22, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.